Miguel-Angel Perales Selected Research

Hematologic Neoplasms (Hematological Malignancy)

10/2022	Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy.
1/2022	Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
1/2022	Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
1/2022	Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
10/2021	Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
10/2021	A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies.
9/2021	Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.
1/2021	Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
11/2020	Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies.
1/2020	Checkpoint inhibitors in AML: are we there yet?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel-Angel Perales Research Topics

Disease

51	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2006
34	Neoplasms (Cancer) 01/2022 - 01/2002
33	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 02/2007
25	Infections 10/2022 - 09/2006
21	Lymphoma (Lymphomas) 01/2022 - 08/2012
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2007
17	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2013
15	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020 - 08/2012
14	Leukemia 01/2022 - 02/2007
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 02/2007
13	B-Cell Lymphoma (Lymphoma, B Cell) 07/2022 - 04/2019
13	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 07/2009
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 10/2015
11	Multiple Myeloma 09/2021 - 07/2015
9	COVID-19 01/2022 - 01/2020
7	Melanoma (Melanoma, Malignant) 01/2013 - 01/2002
6	Viremia 07/2022 - 10/2011
5	Cytomegalovirus Infections (Inclusion Disease) 07/2022 - 01/2016
5	Bronchiolitis Obliterans Syndrome 01/2022 - 10/2006
4	Neutropenia 01/2022 - 10/2011
4	Cytopenia 11/2021 - 01/2019
4	Cytokine Release Syndrome 01/2021 - 01/2020
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 02/2014
3	cell-associated neurotoxicity 01/2021 - 01/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2019 - 10/2015
3	Communicable Diseases (Infectious Diseases) 09/2006 - 01/2002
2	Invasive Fungal Infections 10/2021 - 01/2020
2	Stomatitis 10/2021 - 11/2013
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2020 - 01/2019
2	Encephalitis (Encephalitis, Rasmussen) 03/2016 - 06/2014
2	Systemic Mastocytosis 01/2016 - 10/2014
2	Experimental Melanoma 09/2006 - 05/2006

Drug/Important Bio-Agent (IBA)

25	Chimeric Antigen ReceptorsIBA 10/2022 - 01/2016
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2015
11	axicabtagene ciloleucelIBA 01/2022 - 04/2019
10	tisagenlecleucelIBA 01/2022 - 04/2019
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2002
9	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 12/2007
9	Calcineurin InhibitorsIBA 01/2022 - 06/2014
8	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 02/2007
7	AntigensIBA 01/2021 - 01/2002
6	VaccinesIBA 01/2018 - 01/2002
5	Monoclonal AntibodiesIBA 01/2022 - 01/2017
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2007
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 02/2007
5	fludarabineIBA 10/2020 - 12/2014
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 03/2014
4	Rituximab (Mabthera)FDA Link 09/2021 - 10/2006
4	Busulfan (Busulfex)FDA Link 01/2020 - 02/2007
4	DNA VaccinesIBA 01/2013 - 01/2002
4	AutoantigensIBA 01/2013 - 04/2004
4	Monophenol Monooxygenase (Tyrosinase)IBA 12/2008 - 04/2004
3	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2019
3	CytokinesIBA 01/2022 - 09/2006
3	Sirolimus (Rapamycin)FDA Link 01/2022 - 03/2014
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 03/2016
3	Voriconazole (Vfend)FDA LinkGeneric 10/2021 - 08/2018
3	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 01/2018
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 03/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2008 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 05/2006 - 04/2004
2	letermovirIBA 07/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 09/2006
2	Proteasome InhibitorsIBA 11/2021 - 01/2020
2	isavuconazoleIBA 10/2021 - 01/2020
2	Fibroblast Growth Factor 7 FDA Link 10/2021 - 11/2013
2	Interleukin-15 (Interleukin 15)IBA 09/2021 - 09/2006
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
2	N 30IBA 11/2020 - 03/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 10/2011
2	SteroidsIBA 01/2020 - 01/2017
2	CreatinineIBA 01/2020 - 01/2019
2	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2020
2	Alemtuzumab (Campath)FDA Link 01/2020 - 12/2014
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 03/2015
2	Micafungin (FK463)FDA Link 08/2018 - 12/2015
2	ABO Blood-Group SystemIBA 01/2018 - 01/2016
2	Brentuximab VedotinIBA 01/2017 - 03/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 11/2013
2	Cancer VaccinesIBA 01/2013 - 12/2008

Therapy/Procedure

69	Cell Transplantation 07/2022 - 02/2014
54	Therapeutics 10/2022 - 01/2002
54	Transplantation 07/2022 - 02/2007
31	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2006
21	Stem Cell Transplantation 01/2022 - 09/2006
11	Drug Therapy (Chemotherapy) 01/2022 - 02/2012
7	Immunotherapy 01/2021 - 01/2002
4	Homologous Transplantation 01/2021 - 02/2007
4	Autologous Transplantation 05/2019 - 08/2012
3	Haploidentical Transplantation 01/2022 - 01/2018
3	Salvage Therapy 12/2021 - 03/2015
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 11/2021
2	Aftercare (After-Treatment) 01/2020 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2020
2	Chemoradiotherapy 11/2013 - 07/2009
2	Ligation 09/2006 - 05/2006